2024 Q4 Form 10-K Financial Statement

#000149315224049837 Filed on December 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024
Revenue $7.400M
YoY Change 12.6%
Cost Of Revenue $3.868M
YoY Change 19.38%
Gross Profit $3.532M
YoY Change 6.0%
Gross Profit Margin 47.73%
Selling, General & Admin $3.926M
YoY Change -20.25%
% of Gross Profit 111.16%
Research & Development $546.0K
YoY Change -18.39%
% of Gross Profit 15.46%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.472M
YoY Change -58.38%
Operating Profit -$940.0K
YoY Change -87.32%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $41.00K
YoY Change 41.38%
Pretax Income -$899.0K
YoY Change -87.83%
Income Tax $5.000K
% Of Pretax Income
Net Earnings -$904.0K
YoY Change -87.1%
Net Earnings / Revenue -12.22%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 226.0M shares 226.0M shares 222.1M shares
Diluted Shares Outstanding 222.1M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $6.000K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $732.0K
Other Receivables
Total Short-Term Assets $2.562M
YoY Change 4.66%
LONG-TERM ASSETS
Property, Plant & Equipment $33.00K
YoY Change 10.0%
Goodwill $1.356M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.389M
YoY Change -9.57%
TOTAL ASSETS
Total Short-Term Assets $2.562M
Total Long-Term Assets $1.389M
Total Assets $3.951M
YoY Change -0.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.247M
YoY Change 30.71%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.247M
Total Long-Term Liabilities $0.00
Total Liabilities $1.247M
YoY Change 30.71%
SHAREHOLDERS EQUITY
Retained Earnings -$19.84M
YoY Change 4.77%
Common Stock $226.0K
YoY Change 5.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.704M
YoY Change
Total Liabilities & Shareholders Equity $3.951M
YoY Change -0.83%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024
OPERATING ACTIVITIES
Net Income -$904.0K
YoY Change -87.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $307.0K
YoY Change -115.78%
INVESTING ACTIVITIES
Capital Expenditures $15.00K
YoY Change -53.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$265.0K
YoY Change 728.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$50.00K
YoY Change
NET CHANGE
Cash From Operating Activities $307.0K
Cash From Investing Activities -$265.0K
Cash From Financing Activities -$50.00K
Net Change In Cash -$8.000K
YoY Change -99.6%
FREE CASH FLOW
Cash From Operating Activities $307.0K
Capital Expenditures $15.00K
Free Cash Flow $292.0K
YoY Change -114.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0837077
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
146 Main Street
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Worcester
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2024 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
771000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1337000 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
546000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
669000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-940000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-7414000 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
41000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2704000 usd
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 405
CY2024 dei Entity File Number
EntityFileNumber
000-28745
CY2024 us-gaap Operating Expenses
OperatingExpenses
4472000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
10746000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7400000 usd
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001022505
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2024Q3 us-gaap Deferred Costs
DeferredCosts
usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CY2024 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2024 SDCH Stock Issued During Period Value For Warrants
StockIssuedDuringPeriodValueForWarrants
usd
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2024 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
CY2024 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CY2023 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024 SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
usd
CY2024Q3 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
usd
CY2023Q3 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
usd
CY2023 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
usd
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2024 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2024 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
usd
CY2024 SDCH Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration
pure
CY2023 SDCH Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Of Net Operating Loss Due To Statute
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsOfNetOperatingLossDueToStatute
pure
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2024 dei Entity Registrant Name
EntityRegistrantName
SideChannel, Inc.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01608
CY2024 dei City Area Code
CityAreaCode
(508)
CY2024 dei Local Phone Number
LocalPhoneNumber
925-0114
CY2024 dei Security12g Title
Security12gTitle
Common Stock, par value $0.001
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Public Float
EntityPublicFloat
16200000 usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
225975331 shares
CY2024 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024 dei Auditor Name
AuditorName
RBSM LLP
CY2024 dei Auditor Location
AuditorLocation
Las Vegas, Nevada
CY2024 dei Auditor Firm
AuditorFirmId
587
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1045000 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1053000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
250000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
732000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834000 usd
CY2024Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
150000 usd
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
385000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
381000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2562000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2448000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
150000 usd
CY2024Q3 us-gaap Assets
Assets
3951000 usd
CY2023Q3 us-gaap Assets
Assets
3984000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
729000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
613000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
515000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1247000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
954000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1247000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
954000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
225975331 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
225975331 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213854781 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
226000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
214000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22321000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21755000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19843000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18939000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2704000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3951000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3984000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7400000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6572000 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
3868000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
3240000 usd
CY2024 us-gaap Gross Profit
GrossProfit
3532000 usd
CY2023 us-gaap Gross Profit
GrossProfit
3332000 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3155000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3586000 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4940000 usd
CY2023 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-899000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7385000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-379000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-904000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7006000 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222078462 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222078462 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175274762 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175274762 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
66000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
360000 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
214000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7006000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2024 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
15000 usd
CY2024 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
543000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-904000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2704000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-904000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7006000 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
192000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
182000 usd
CY2024 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
15000 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
563000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
405000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000 usd
CY2023 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4940000 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-102000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
225000 usd
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
61000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
116000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-363000 usd
CY2024 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-8000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-184000 usd
CY2024 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
235000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
150000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
307000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1945000 usd
CY2024 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
250000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-265000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000 usd
CY2024 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1977000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1053000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3030000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1045000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1053000 usd
CY2023 SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
21000 usd
CY2024 us-gaap Stock Issued1
StockIssued1
20000 usd
CY2023 us-gaap Stock Issued1
StockIssued1
66000 usd
CY2024 SDCH Purchase Of Restricted Stock Units Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRestrictedStockUnitsSoldByEmployeesToPayForTaxesDueOnVestedRsus
119000 usd
CY2023 SDCH Purchase Of Restricted Stock Units Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRestrictedStockUnitsSoldByEmployeesToPayForTaxesDueOnVestedRsus
59000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-904000 usd
CY2024 us-gaap Other Noncash Expense
OtherNoncashExpense
755000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
307000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8000 usd
CY2024 SDCH Cash For Investing And Financing Activities
CashForInvestingAndFinancingActivities
315000 usd
CY2024 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
250000 usd
CY2024 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zqiHTf1XdBo9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zfORPzs8D2Eg">Reclassifications</span></span></i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain prior year amounts have been reclassified to be comparable with the current year’s presentation or adjusted due to rounding and have had no impact on net income or stockholders’ equity.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4900000 usd
CY2023Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2024Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q3 SDCH Milestone Revenue
MilestoneRevenue
5500000 usd
CY2024Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
6000 usd
CY2023Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
42000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42000 usd
CY2024 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
250000 usd
CY2021Q4 us-gaap Area Of Land
AreaOfLand
500 sqft
CY2021Q4 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
option to renew annually for three twelve-month periods through December 2025. The annual renewal date is January 1st.
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
967 usd
CY2024 us-gaap Operating Lease Expense
OperatingLeaseExpense
12000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
10000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
250000 usd
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
250000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
225975331 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
0 shares
CY2023 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
0 shares
CY2024 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
0 shares
CY2023Q3 SDCH Investor Warrants Included In Tender Offer To Exchange
InvestorWarrantsIncludedInTenderOfferToExchange
69281020 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6572000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2023 SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
553000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
403000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2024 SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
1258000 usd
CY2024 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1023000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
515000 usd
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
682000 usd
CY2024 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2024 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
662000 usd
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
662000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
485000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
66000 usd
CY2023 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
419000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0436 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.8297 pure
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M1D
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-136000 usd
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-32000 usd
CY2024 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
5000 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-168000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-211000 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-211000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-379000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
-0.0027 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
-0.0022 pure
CY2023 SDCH Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration
-0.0189 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.1288 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.0158 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.2691 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0302 pure
CY2024 SDCH Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Of Net Operating Loss Due To Statute
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsOfNetOperatingLossDueToStatute
-0.3665 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.5571 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1836 pure
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0513 pure
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-379000 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
34200000 usd
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
525000 usd
CY2024 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. Future ownership changes may trigger Section 382 and therefore, substantially limit the amount of pre-Combination NOLs that can be utilized annually to offset future taxable income.
CY2024 SDCH No Insider Trading Flag
NoInsiderTradingFlag
true

Files In Submission

Name View Source Status
0001493152-24-049837-index-headers.html Edgar Link pending
0001493152-24-049837-index.html Edgar Link pending
0001493152-24-049837.txt Edgar Link pending
0001493152-24-049837-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
form10-k_003.jpg Edgar Link pending
form10-k_004.jpg Edgar Link pending
logo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdch-20240930.xsd Edgar Link pending
Show.js Edgar Link pending
sdch-20240930_def.xml Edgar Link unprocessable
sdch-20240930_lab.xml Edgar Link unprocessable
sdch-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
sdch-20240930_cal.xml Edgar Link unprocessable